Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          FDA Releases Data from the Agency’s Year-Long Sampling Assignment to Test Talc-Containing Cosmetic Products for the Presence of AsbestosCFSAN Constituent Updates FDA Releases Data from the Agency’s Year-Long Sampling Assignment to Test Talc-Containing Cosmetic Products for the Presence of Asbestos
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintConstituent Update

March 9, 2020

The U.S. Food and Drug Administration (FDA) has released a final report in six parts from the agency’s year-long sampling assignment of testing talc-containing cosmetic products for the presence of asbestos, performed by AMA Analytical Services, Inc. (AMA).

In September 2018, AMA was awarded a one-year contract to test talc-containing cosmetics for the presence of asbestos fibers. AMA was selected because of its expertise and knowledge in asbestos testing, as well as having conducted a previous successful survey for the FDA. For this assignment, a contract was established with AMA to test talc-containing powder cosmetic products, which were selected and purchased by the FDA and were provided to AMA as blinded samples. The results showed that 43 samples were negative while 9 were positive.

The products were selected based on various factors including: type of talc-containing powder cosmetic product, price range (i.e., low end to high end products), popular products on social media and in advertisements, children’s products, as well as certain products that had been reported by third parties to be contaminated with asbestos. As such, the occurrence of positive samples in the 2019 testing should not be interpreted as reflecting the overall frequency of positive samples in the marketplace.

In the case of the positive samples, when the FDA received those test results from AMA, the agency immediately notified the public about the results, and worked closely with the affected companies on their subsequent recalls.

For testing purposes, AMA used Polarized Light Microscopy (PLM) and Transmission Electron Microscopy (TEM) to detect and quantify mineral particles suspected of being a form of asbestos. TEM is currently the most sensitive testing method for the detection and quantification of asbestos minerals.

The FDA is planning to continue its talc sampling assignment throughout 2020, with 50 samples selected for blinded testing by AMA. Those final results will be released when available in early 2021. If the FDA finds positive samples, the agency will once again inform the public of the results, and will work closely with the companies involved to remove affected products from the market.

**Additional Information:**

FDA In Brief
	Talc Web Page
	Cosmetic Recalls & Alerts

                                                                                  Content current as of:
      03/09/2020
              
              
Regulated Product(s)
		 Food & BeveragesCFSAN Constituent Updates
 Subscribe to CFSAN Constituent Updates
                        Get email updates delivered to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop